A combination of analgesic and antagonist in postoperative pain by Hossli, Georg & Bergmann, Greta
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 1960
A combination of analgesic and antagonist in postoperative pain
Hossli, Georg; Bergmann, Greta
DOI: https://doi.org/10.1093/bja/32.10.481
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: https://doi.org/10.5167/uzh-154101
Journal Article
Published Version
Originally published at:
Hossli, Georg; Bergmann, Greta (1960). A combination of analgesic and antagonist in postoperative
pain. British Journal of Anaesthesia, 32(10):481-485.
DOI: https://doi.org/10.1093/bja/32.10.481
Brit. J. Anaesth. (1960), 32, 481
A COMBINATION OF ANALGESIC AND ANTAGONIST
IN POSTOPERATIVE PAIN
BY
G. HOSSLI AND G. BERGMANN
The Department of Anaesthesia, Umversitdtsklinik, Zurich, Switzerland
Clinicians often hesitate to give adequate doses of
narcotic analgesics such as morphine and pethi-
dine because these compounds are known to have
a marked respiratory depressant effect. As a result
there has been considerable interest in the possi-
bility of combining a dose of one of these anal-
gesics with a small quantity of one of the specific
narcotic antagonists. The latter substances are
known to exert a much greater antagonism to the
respiratory depressant effect than to the analgesic
action of the narcotics.
When deciding on such a combination the first
prerequisite is that the antagonist should have
few undesirable effects of its own and the second
is that the antagonist and the analgesic should
have approximately the same length of action.
Although the narcotic antagonists nalorphine
and levallorphan themselves possess slight respi-
ratory depressant activity, this is insignificant in
the doses in which they are used clinically.
Levallorphan was chosen for clinical trial because,
even in large doses such as are rarely used in
therapy, it is tolerated without undesirable side
effects by both conscious and unconscious patients
(Swerdlow, 1958). Pethidine was selected as the
analgesic most likely to have a suitable length of
action for combination with levallorphan.
Having decided on the combination of drugs
we set out to establish whether, using the two
drugs together in suitable proportions, the
presence of the antagonist influences the
following:
the respiratory depressant effect of pethidine;
the analgesic activity;
the incidence of side effects.
Accordingly, the following studies were carried
out.
Influence on Respiratory Depression
In order to study the influence of levallorphan on
the respiratory depressant effect of pethidine, it
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was necessary first to establish the optimal pro-
portions of the two drugs. Accordingly preli-
minary tests were carried out in 25 individuals
who were about to undergo surgical operations.
The patients were premedicated with a barbi-
turate and atropine (0.25-0.5 ing), pethidine-
like drugs being deliberately avoided. Anaesthesia
was induced with thiopentone. The patient was
intubated after relaxation had been achieved with
suxamethonium and anaesthesia was maintained
with nitrous oxide and oxygen. When breathing
had become regular and tranquil, an intravenous
dose of pethidine 1-2 mg/kg was given, accom-
panied by, or followed by, a dose of levallorphan.
Various ratios between 80:1 and 35:1 were
studied. After this the respiratory rate and minute
volume were measured at intervals. It was found
that the ratio of pethidine to levallorphan of 80:1
had no greater respiratory depressant effect than
the ratio of 35:1 and as a result the 80:1 ratio
was chosen for the main test.
For this test two groups, each of 15 patients,
were studied under accurately standardized con-
ditions and the results have been reported in
detail elsewhere (Hossli and Bergmann, 1959). In
brief, the patients were anaesthetized as described
above and, when breathing had become regular,
each patient was given an intravenous injection of
pethidine 1 mg/kg alone or combined with leval-
lorphan in the ratio of 80:1. The respiratory rate
and minute volume were measured every minute
for 20 minutes, and figure 1 shows our findings.
Statistical analysis of the figures for the respira-
tory rate, minute volume and alveolar ventilation
at 2, 3, 6, 12 and 20 minutes after giving the
pethidine or pethidine plus levallorpban showed
that, compared with the initial readings, all these
figures were reduced more by pethidine than by
pethidine with levallorphan. The difference was
statistically significant on all occasions except for
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readings for minute volume and alveolar ventila-
tion at 12 minutes.
It was thus shown that pethidine with levallor-
phan in the proportion of 80:1 causes signi-
ficantly less respiratory depression than does
pethidine alone.
Effect on the Analgesic Activity
In order to compare the analgesic activity of
pethidine with that of pethidine plus levallorphan
a double blind control study was carried out in 96
individuals who needed a narcotic analgesic for
the relief of postoperative pain. Sixty-four of
these patients had undergone major thoracic or
abdominal operations, 4 had had minor abdom-
inal operations (appendicectomy or laparotomy)
and the rrmaining 28 had undergone operation
for hernia, sympathectomy, mastectomy or opera-
tions on the limbs. A dose containing 50, 75 or
100 mg of pethidine, alone or with levallorphan
(ratio 80:1), was given according to the patient's
need. Ampoules were labelled with code numbers
in order that the trial should be blind to all
concerned in it.
Before the administration of any analgesic the
severity of the pain was recorded, based on the
patient's own statement and also on the impres-
sion of the observer, using the following scheme:
no pain 0; mild pain 1; moderate pain 2; severe
pain 3; intolerable pain 4.
After the injection the severity of the pain was
recorded by the same method at 30-minute inter-
vals for a period of 4 hours. A calculation was
made at each half-hourly period of the difference
between the score for pain at that moment and
the score for the initial pain. The sum-total of
these differences was taken to be the figure repre-
senting the "total analgesic activity" of a single
dose of the drug concerned.
If it was necessary to give additional doses to
the same patient, then ampoules with the same
code number were used throughout. The sizes of
additional doses were adjusted, if necessary, to the
patient's response and a repeat dose of analgesic
was given only if the effect of the previous dose
had worn off.
It would have been desirable to have had all
the observations carried out by the same indiv-
idual. However, as this was not possible, care was
taken to ensure that the same observer made all
the observations in a given patient over the whole
4-hour period.
Results.
In total, 219 doses of analgesic were given. On
breaking the code, it was found that 49 patients
had been given a total of 154 injections of pethi-
dine plus levallorphan. The content of pethidine
was 50 mg on 65 occasions, 75 mg on 43 occa-
sions and 100 mg on 46 occasions. The other
group, given pethidine alone, comprised 47
patients who had been given a total of 137 injec-
tions; the dose was 50 mg on 51 occasions, 75 mg
on 52 occasions and 100 mg on 34 occasions. The
number of doses given to single individuals varied
from one to seven, the average being 3.1 in the
pethidine with levallorphan group and 2.9 in the
pethidine group.
In the pethidine with levallorphan group the
patient's ages varied between 19 and 73 years
(average 47). Their weight varied between 40 and
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92 kg (average 65.2). In the pethidine group, the
figures were: age between 20 and 79 years (aver-
age 49) and weight between 45 and 97 kg (average
68.8). As regards the types of operation, the dis-
tribution was similar in the two groups.
In occasional patients it was necessary to inter-
rupt the observations before the end of the 4-hour
period for reasons unconnected with the triaL In
these patients the pain had not returned to its
initial severity at the time when the readings were
interrupted. In order not to reduce too much the
numbers in each group by omitting these incom-
plete observations we have also included in the
average figures for "analgesic activity" readings
taken at 3^ - and 3 hours.
In addition, on the very few occasions in which
a half-hourly reading was omitted we took for the
calculation the lower of the two figures on each
side of the missed reading.
Tahle I shows the findings in the three sub-
groups, after 50-mg, 75-mg and 100-mg doses of
pethidine with or without levallorphan, as well as
the number of injections given at each dose level.
As can be seen from this table, the figures show
that there is extraordinarily good agreement in all
three groups as regards the average analgesic
activity of a single dose of pethidine or pethidine
with levallorphan after 3, 3i and 4 hours. It can
also be seen that the average figures for the anal-
gesic effect of a dose increased with the time
(that is with the number of observations), and
that in general larger doses gave better analgesia
than smaller doses.
Statistical analysis of these figures, using the
t-test, showed that at the three dose levels there
was no significant difference between the average
analgesic activity of pethidine and that of pethi-
dine with levallorphan.
On the basis of these findings it can be con-
cluded that the addition of the narcotic antagonist
levallorphan to pethidine in the above proportion
does not interfere with the analgesic activity of
the pethidine.
Influence on the Incidence of Side Effects
As regards the general clinical use of the combin-
ation of pethidine with levallorphan an important
question is raised. Does the antagonist prevent not
TABLE I
Mean figures for the "analgesic activity" of a single dose of pethidine
or pethidine with levallorphan.
Observa-
tion
period
(hours)
50 mg
pethidine
75 rag
pethidine
100 mg
pethidine
n
Pethidine
Pethidine +
levallorphan
13.3 51
14.6 47
14.8 37
13.5 65
15.0 61
16.4 49
13.0 52
14.7 49
16.1 41
13.2
14.6
15.8
43
41
40
15.1 34
17.1 33
18.5 29
14.4 46
16.0 44
17.6 38
A=average analgesic activity of a single dose.
n = number of injections.
TABLE
Incidence of side effects after pethidine and pethidine with levallorphan.
Pethidine
Pethidine +
levallorphan
TotaJ
no. of
patients
51
53
Total no.
of injec-
tions
162
171
•Patients
with side-
effects
15°
16»
Nature of
Nausea
P
11
10
n
12
15
side
Vomiting
P
9
4
n
11
4
effects
Sweating
P
2
6
n
3
8
(* Some patients experienced more than one side effect.)
P=number of patients.
n=number of injections.
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only respiratory depression but also other undes-
irable effects of pethidine, especially nausea and
vomiting? In our study in postoperative patients
we recorded the presence or absence of nausea
and vomiting and, as far as possible, other side
effects that might have been associated with
medication. Some additional patients were
included who could not be used for assessment of
the analgesic effect.
Table II shows the incidence of nausea, vomit-
ing and excessive sweating in the two groups. A
breakdown into three dose levels is omitted, as it
was not possible to show that there was a relation-
ship between the presence of such side effects and
the size of the dose. It was found that the incid-
ence of nausea was the same in the two groups.
Vomiting was somewhat less common in the
pethidine with levallorphan group, whilst exces-
sive sweating was rather more frequent. However,
these differences were not statistically significant.
No other significant side effects were observed.
In the pethidine with levallorphan group each of
the following were observed on one occasion:
restlessness, tachycardia, arrhythmia, vertigo, pal-
pitations and flushing. In two patients in the
pethidine series there was a considerable rise of
blood pressure (possibly a result of hypoventila-
tion).
DISCUSSION
The results of our previous investigation confirmed
the protective effect of levallorphan against the
respiratory depressant effect of pethidine.
The study in postoperative pain showed that,
in the dose ratio of 80:1, the analgesic effect of
pethidine on postoperative pain is not reduced by
levallorphan. As regards the incidence of side
effects other than respiratory depression, this was
similar in the two groups. Although we found
that the incidence of vomiting after pethidine
with levallorphan was somewhat reduced and
excessive sweating was slightly increased, the dif-
ferences were not statistically significant.
When using pethidine the addition of a small
dose of levallorphan provides a greater margin of
safety and permits the administration of adequate
doses without the fear of inducing serious respira-
tory depression. The following two cases which
occurred fairly recently in our clinic illustrate the
fact that severe respiratory depression may occur
even when using pethidine in the usual
therapeutic doses.
A woman, aged 39 years, had been admitted to hos-
pital for an operation. Some hours after the operation
she was found to be unconscious, cyanosed and with
dilated pupils; spontaneous respiration was absent.
Oxygen was applied immediately and an endotracheal
tube was passed. Ten minutes later, regular spon-
taneous respiration had returned and after 4 hours
the patient had recovered completely. Later it was dis-
covered that because of postoperative pain she had
been given an intramuscular injection of pethidine 100
mg about 30 minutes before the above incident
occurred.
A man, aged 73 years, with emphysema had been
subjected to prostatectomy. During the night the
patient was erroneously given pethidine 100 mg intra-
venously instead of Novalgin. The physician, who was
called immediately, observed that the patient had
slow, gasping respiration, was unconscious and had
constricted pupils (the clinical appearances seen in
morphine poisoning). Oxygen was administered and
an endotracheal tube was passed. However, it was
necessary to administer levallorphan 2 mg before
spontaneous respiration improved and the reflexes
returned. One hour later the patient was again
conscious.
These two experiences confirm the fact that
there is variation in individual sensitivity to res-
piratory depressant substances and that even
therapeutic doses can cause serious complications.
Without rapid medical assistance the apnoea
might well have resulted in death, or at least in
severe hypoxic damage.
SUMMARY
The authors describe a series of studies designed
to establish whether the addition of a small quan-
tity of the narcotic antagonist levallorphan
reduces the respiratory depressant action of pethi-
dine. They also investigated the effect on
analgesic activity and on the incidence of side
effects.
The study of respiratory depression was carried
out in two groups of anaesthetized patients. When
anaesthesia was established each patient was given
a dose of pethidine 1 mg/kg alone or mixed with
levallorphan in the proportion of 80:1. The
results showed that there was a statistically signi-
ficantly smaller reduction of the respiratory rate,
minute volume and alveolar ventilation in the
pethidine plus levallorphan group.
To investigate the analgesic activity two groups
of patients with postoperative pain were treated
in a blind control study with either pethidine or
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pethidine with levallorphan in the above propor-
tion. It was found that the average analgesic acti-
vity was almost the same with the two types of
treatment. The incidence of side effects between
the two groups was insignificantly different.
The authors conclude that the addition of leval-
lorphan in the above proportion gives almost
complete protection against the respiratory
depressant effect of pethidine without diminishing
the analgesic effect and without increasing the
incidence of side effects.
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FILM REVIEW
"THAT THEY MAY LIVE"
This film is excellent not only from the teaching
point of view but also in its presentation and pro-
duction It is dramatic and holds the interest of
the viewers throughout. There is a tendency to
react against the presentation of medical tech-
niques which picture teaching accompanied by all
the trappings commonly employed by the com-
mercial film industry. For example, music and the
employment of over-dramatic situations some-
times detract from useful teaching films. Never-
theless these are so skilfully employed in the
production under review that they positively add
to the teaching value of the film.
The film shows the experiences of a newspaper
reporter who visits the University of Saskat-
chewan Hospital with the intention of writing up
modern methods of artificial respiration. He sees
a demonstration of mouth-to-mouth resuscitation
carried out on a paralyzed subject and its efficacy
contrasted with that of the more usual methods
available to the first-aid workers. He sees a class
being instructed in the technique with the aid of
a wooden "air passage demonstrator" and an
excellent "manikin". The direct mouth-to-mouth
method is shown and also the more hygienic use
of the Brook Airway. The reporter is then shown
a film demonstrating "action shots" of a variety
of accidents: a car collision; a drowning incident;
a child trapped in an abandoned icebox; an infant
suffocated by a plastic bag; an electrocution
occurring at the top of a pylon; a choking scene
in a restaurant; all of these being dealt with by
members of the general public by mouth-to-
mouth resuscitation. Finally, the reporter himself
on leaving the hospital visits a fun-fair and is
called upon to use the technique in the resuscita-
tion of a case of electrocution.
This is quite the best film of its type that the
reviewer has seen and should be in wide demand
for showing to undergraduates, nurses, ambulance
personnel and first-aid workers.
This film is available from Messrs. Smith and
Nephew Ltd., Bessemer Road, Welwyn Garden
City, Herts, who also supply the airway passage
demonstrator and the Brook Airway.
Cecil Gray
